3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Stomach Neoplasms
5
Colorectal Neoplasms
5
Sarcoma
2
Endometrial Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Pancreatectomy
1
Ovarian Neoplasms
1
Neoplasms
1
Motor Activity
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Heart Defects, Congenital
1
Gynecologic Surgical Procedures
1
Gynecologic Cancer
1
Gastrointestinal Neoplasms
1
Frailty
1
Coma
1
Colonic Neoplasms
1
Cerebrovascular Disorders
1
Carcinoma, Hepatocellular
1
Brain Injuries, Traumatic
1
Interventions
Paclitaxel
10
Surveys and Questionnaires
6
Cisplatin
6
Carboplatin
5
pembrolizumab
4
Brachytherapy
4
Hyperthermic Intraperitoneal Chemotherapy
3
Gemcitabine
3
Doxorubicin
3
Docetaxel
3
olaparib
2
niraparib
2
durvalumab
2
Topotecan
2
Taxes
2
Standard of Care
2
Sentinel Lymph Node Biopsy
2
Saline Solution
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Music Therapy
2
Mitomycin
2
Letrozole
2
Imagery, Psychotherapy
2
Hysterectomy
2
Exercise
2
Everolimus
2
Blood Specimen Collection
2
ulipristal acetate
1
temsirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Neoplasms
×
Enhanced Recovery After Surgery
×
Clear all
NCT04063072
2021-06-02
ERAS-Gyneco
Ospedale Regina Montis Regalis
Phase NA
Unknown
1,800 enrolled